Top Players in the Bacteriophage Market (2025-2035) The global bacteriophage market, valued at USD 45.07 million in 2023, is projected to reach USD 68 million by 2033, growing at a CAGR of 4.2% over the forecast period. The increasing adoption of bacteriophages in dietary supplements and medical treatments is fueling market expansion. These specialized viruses target harmful bacteria, reducing the risk of foodborne infections and offering a promising alternative to traditional antibiotics. With antibiotic resistance becoming a global concern, phage therapeutics are emerging as a viable solution for treating bacterial infections, including urinary tract infections and dysentery. The growing demand for personalized medicine and advancements in phage therapy research are further driving industry growth. Scientists and healthcare professionals are increasingly exploring bacteriophage applications for targeted treatment approaches, enhancing patient outcomes. The surge in bacterial infections due to factors such as aging populations, climate change, and increased global travel is further accelerating the adoption of bacteriophage solutions. Governments and private sector players are actively investing in research and development to advance phage-based therapies, aiming to combat rising antimicrobial resistance. As a result, the industry is witnessing significant advancements in formulation techniques and clinical applications. Request a Sample of this Report Now: https://www.futuremarketinsights.com/report-sample#5245502d47422d3134343631